reaches 2,500 videos

Share this article:
Physician-generated video platform has accumulated 2,500 videos, and will launch advertising on the site in the coming months.

The site, which officially launched last July, has been compiling patient education videos created by physicians and other healthcare practitioners, and will launch advertising in February or March at the latest, according to Dean Heller, president. 

“Pharma will clearly be our main advertisers—we have a number of calls from some of the bigger companies already,” said Heller.

Physicians can use the site to introduce their practice, educate on a specific disease, explain a procedure, or communicate with patients' families, among other things, said Heller. can provide individualized pages for a doctor's practice, and offers customizable search engines – videos can be searched by name and city exclusively, for example.

To upload videos, physicians and other healthcare practitioners must include a hospital affiliation during the registration process. Manufacturers can create searchable branded videos if they also agree to advertise on the site, said Heller. 
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?